id: NEW:glycinergic_system_pharmacological_targeting_to_alcohol_use_disorder
name: Glycinergic System Pharmacological Targeting â†’ Alcohol Use Disorder
from_node:
  node_id: NEW:glycinergic_system_pharmacological_targeting
  node_name: Glycinergic System Pharmacological Targeting
to_node:
  node_id: alcohol_use_disorder
  node_name: Alcohol Use Disorder
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Current approved AUD medications display modest effect sizes, creating treatment gaps'
- 'Step 2: Pharmacotherapy targeting the mechanism by which ethanol activates dopamine reward pathway
  offers improved outcomes'
- 'Step 3: Glycine receptors in nucleus accumbens are involved in basal and ethanol-induced dopamine release'
- 'Step 4: Elevating central glycine levels (via direct glycine or GlyT-1 inhibition) modulates this pathway'
- 'Step 5: Reduced ethanol intake and preference may translate to improved AUD treatment outcomes'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Y. Olsson et al. 2020. "Effects of systemic glycine on accumbal glycine and dopamine
    levels and ethanol intake in male Wistar rats." https://doi.org/10.1007/s00702-020-02284-x
  supporting_citations:
  - Abstract references approved AUD medications having modest effect sizes
  - Abstract references prior GlyT-1 inhibitor studies
  - Additional citations require full-text access
  doi: 10.1007/s00702-020-02284-x
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The glycinergic system represents a potential pharmacological treatment principle for AUD,
  as elevating central glycine levels reduces ethanol intake by modulating the dopamine reward pathway
  that mediates alcohol's reinforcing effects.
structural_competency:
  equity_implications: This research addresses a structural gap in AUD treatment - the limited efficacy
    of current approved medications. Developing more effective pharmacotherapies is critical given that
    AUD treatment access and quality vary significantly by socioeconomic status, race, and geography.
    Novel treatments could help reduce these disparities if equitably distributed through community health
    centers, Medicaid programs, and integrated care settings.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.143968'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
